Clinical Group
RSS Feeds Peertechz

Global Journal of Cancer Therapy  Open Access

    Introduction

    • Volume/IssueClick here
    • Review ProcessDouble Blind
      • Publication lead time3 - 4 weeks
      • Indexing statusYes; Purview
      • Manuscript Processing ChargesClick here
      • Submission ChargesNo
      • Waiver policy for APCYes
      • Language of Full TextEnglish
      • Full-text formats availablePDF, HTML
    • Show +
    • Permanent article identifierDOI (Digital Object Identifier)We provide DOI to all published papers. It'll facilitate for higher citation and classification.
      Peertechz Publisher ID: 10.17352
    • Type of LicenseCreative Commons
      • Open AccessYes; Policy
      • Does the author retain unrestricted copyright?Yes
      • Does the author retain publishing rights?Yes
    • Show +

    Editor-in-Chief

    M.Waheed Roomi

    M.Waheed Roomi
    Dr. Rath Research Institute
    1260 Memorex Drive, Santa Clara, USA
    Email: w.roomi@drrath.com
    Tel: (408)730-4481
    Fax: (408) 588-7174

    More Info.

    Welcome from the desk of

    Dr. Tsuyoshi Shirakawa, MD., Executive Editor

    Welcome to our website! I am very happy for your visit.

    Global Journal of Cancer Therapy reports both clinical and experimental results related to cancer, and is using online review and Editorial Manager System for quality review process. The Journal invites all type of clinical and medical case reports, case studies, basic researches, clinical images, pharmacology and nursing, as it were, total oncology. The goal of us is to keep a record of the state-of-the-art research or case report and to promote study, research and improvement within its various specialties, then to develop total oncology.

    We believe your expertise knowledge will help in the growth of the journal and as well help many budding research scientists all around the world. Your article will be a key insight into real medical cases that are essential for physicians, and may ultimately help to improve patient outcomes.

    Executive Editors

    Tsuyoshi Shirakawa
    Office Doctor
    Department of Medicine
    Kyushu University
    Japan
    t-w-r@intmed1.med.kyushu-u.ac.jp
    GJCT

    After I graduated from Kyushu University Graduate School of Medical Sciences in 2004, I started junior residency at Kyushu Medical Center and Kyushu University hospital from 2004 to 2006. Next, I worked as a senior resident at Kyushu Cancer Center hospital in 2006. Then, I researched about cancer stem cells at Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Science.
    I got Diplomate, Subspeciality Board of Medical Oncology in 2012, and worked as a chief resident National Cancer Center Hospital, Tokyo. At National Cancer Center Hospital, I researched about esophageal cancer chemotherapy mainly.
    Then, I joined and worked at the department of Gastrointestinal and Clinical Oncology Division of Kyushu Cancer Center Hospital from 2013 to 2015. From 2015 to 2017, I was a head of Oncology division of Miyazaki Prefectural Miyazaki Hospital, and a main and leading member of Kyushu Medical Oncology Group and Kyushu-Yamaguchi Total Oncology Group, respectively. Now in 2018, I work in Karatsu Higashi-matsuura Medical Association Center as a doctor of internal medicine.

    Research Interest:

    Medical Oncology (Mainly Gastrointestinal Cancer), Cancer stem cell (Basic research), Palliative medicine, General Medicine, Gastroenterology, Clinical study, Multi-disciplinary coordination and multi-disciplinary study.

    Publications:

    Original articles
    Acute lymphoblastic leukemia presenting with calcineurin-inhibitor induced pain syndrome after a second allogeneic bone marrow transplantation. Rinsho Ketsueki. 2006 Oct;47(10):1372-6.

    A retrospective study of docetaxel or paclitaxel in patients with advanced or recurrent esophageal squamous cell carcinoma who previously received fluoropyrimidine- and platinum-based chemotherapy. Cancer Chemother Pharmacol (2014) 74:1207-15, DOI 10.1007/s00280-014-2597-3.

    Improvement in the awareness of palliative care nursing using STAS-J in an acute care hospital. J Palliat Care Med 2015, 5:3 http://dx.doi.org/10.4172/2165-7386.1000219.

    Retrospective analysis of cardiovascular diseases related to chemotherapies for advanced solid tumor patients. Anti-Cancer Drugs. 2016 Oct; 27(9): 891-8.

    Analysis of a questionnaire survey regarding current conditions against exposure to anticancer drugs and reports of cancer chemotherapy at outpatient departments in Japan. Pharmacology & Pharmacy, 2017, 8, 140-152.

    Human Nanog pseudogene8 promotes the proliferation of gastrointestinal cancer cells. Exp Cell Res. 2012 Sep 10;318(15):1799-807.

    Human STEAP3 maintains tumor growth under hypoferric condition. Exp Cell Res. 2011 Nov 1;317(18):2582-91.

    Pemetrexed combined with platinum-based chemotherapy for advanced malignant peritoneal mesothelioma: retrospective analysis of six cases. Anticancer research 2014, 34: 215-220.

    Analysis of adverse events of bevacizumab-containing systemic chemotherapy for metastatic colorectal cancer in Japan. Anticancer research 2014, 34: 2035-2040.

    Efficacy and safety analysis of chemotherapy for advanced colitis-associated colorectal cancer in Japan.
    Anti-Cancer Drugs 2016, 27(5): 457-63.

    Efficacy and Safety of TAS-102 in clinical practice of salvage chemotherapy for metastatic colorectal cancer. Anticancer Research 2016 Apr; 36(4): 1959-66.

    Safety and tolerability of the olaparib tablet formulation in Japanese patients with advanced solid tumours. Cancer Chemother Pharmacol, 2016 Jul 15 DOI 10.1007/s00280-016-3106-7.

    Five-weekly S-1 plus cisplatin therapy combined with trastuzumab therapy in HER2-positive gastric cancer: a phase II trial and biomarker study (WJOG7212G). Gastric Cancer. 2017 May 11 DOI: 10.1007/s10120-017-0725-6.

    Suggestion of added value by bevacizumab to chemotherapy in patients with unresectable or recurrent small bowel cancer. Cancer Chemotherapy Pharmacology, 2017 Jun 26. DOI 10.1007/s00280-017-3371-0.

    Irinotecan mnotherapy as third-line or later treatment in advanved gastric cancer. Gastric Cancer, 21(3), 464-472 DOI 10.1007/s10120-017-0759-9.

    Early tumor shrinkage indicates a favorable response to bevacizumab-based first-line chemotherapy for metastatic colorectal cancer. Anticancer Drugs, 2017 Sep 12 DOI 10.1097/CAD.0000000000000562.

    Anti-Epidermal Growth Factor Receptor Antibody Readministration in Chemorefractory Metastatic Colorectal Cancer. Anticancer Res. 2017 Nov;37(11):6459-6468.

    Corresponding author
    Successful chemoradiotherapy for neuroendocrine tumor grade 3 arising from the mandibular gingiva: a case report and literature review. Open Journal of clinical & medical case report, Volume 2 (2016) Issue 5: 1089.

    Case reports
    A complete response to second-line chemotherapy with sunitinib of a gastrointestinal stromal tumor: A case report. Molecular and Clinical Oncology 2017 Jul; 7(1): 93-97.

    Improvement of quality of life and survival using self-expandable metal stent placement for severe malignant stenosis of the gastric body: a case report. J Med Case Rep. 2012, 6:315.

    Systemic chemotherapy for metastatic non-mucinous appendiceal adenocarcinoma: a case report and literature review. Int canc conf J. 2012 Oct DOI10.1007/s13691-012-0060-z.

    Successful Chemoradiotherapy for undifferentiated malignant neoplasm arising from the left pulmonary artery Case Rep Oncol 2014;7:484-490.

    Successful multimodal therapy for undifferentiated carcinoma with neuroendocrine differentiation in the clival region. Int canc conf J. 2014 July DOI 10.1007/s13961-014-0179-1.

    Anti-HER2 combination chemotherapy for advanced gastric cancer associated with the Peutz-Jeghers syndrome: a case report and literature review. Int canc conf J. 2013 Nov DOI 10.1007/s13961-013-0139-1.

    Favorable control of advanced colon adenocarcinoma with severe bone marrow metastasis. Molecular and Clinical Oncology 5: 579-582, 2016.

    More Info.

    Editorial Board

    Maria Saridi
    Director Nursing
    University of Peloponnese
    Greece
    sarmar32@windowslive.com
    GJCT
    Research Interest: Nursing Care Delivery Systems, Community Nursing, Hospital Information Systems, Surgical Nursing, Health Education, Prevention, Nosocomial Infections, Occupational Health, Community Healthcare
    More Info.
    Christopher Xin Jie Wong
    Centre for Heart Rhythm Disorders
    Royal Adelaide Hospital
    South Australia
    c.wong@adelaide.edu.au
    GJCT
    Research Interest: Dr Wong’s Research Interests Focus On The Mechanisms, Clinical Treatment And Public Health Implications Of Cardiovascular Disease.
    More Info.
    Gang Du
    Shanghai Jiaotong University
    China
    gdu@dbm.ecnu.edu.cn
    GJCT
    Research Interest: Clinical Tumour Classification And Diagnosis, Data Mining In Healthcare, Clinical Pathway Modeling, Simulation And Scheduling Optimization, Decision-Making In Healthcare  
    More Info.
    Qinong Ye
    Professor
    Department of Medical Molecular Biology/Oncology
    Beijing Institute of Biotechnology
    China
    yeqn66@yahoo.com
    GJCT

    Research Interest: Molecular Basis Of Cancer; Cell Signaling; Epigenetics; DNA Damage Response


    More Info.
    Fan Song
    Sun Yat-Sen University
    China
    fansong8888@163.com
    GJCT

    Research Interest: Minimal Invasion, Endoscopically Assisted Selective Neck Dissection, Functional Reconstruction, Mitochondrial Fission, Cisplatin Sensitivity, Mirna, Lncrna


    More Info.
    Zbigniew Antosz
    Department of Pathology
    Regional Specialistic Hospital
    Poland
    antosz@mp.pl
    GJCT

    Research Interest: Histopathology, Anatomical pathology, Experimental oncology


    More Info.
    Peng Zhan
    Associate Professor
    Shandong University,
    China
    zhanpeng1982@163.com
    GJCT

    Research Interest: Discovery of Novel Antiviral, Anticancer and Neurodegenerative Diseases-Related Agents Based on The Rational Drug Design Approaches.


    More Info.
    George F Samelis
    Medical Oncologist
    President of the Hellenic and International Society of Molecular
    National and Kapodistrian University of Athens
    Greece
    oncologydept.samelis@hippocratio.gr
    GJCT

    Research Interest: Lung-Pancreatic-Prostate-Cancers, Molecular Targeted Therapies


    More Info.
    Tomasz Skora
    Gastrointestinal and Genitourinary Cancer
    Maria Sklodowska-Curie Memorial Institute
    Poland
    tbskora@gmail.com
    GJCT

    Research Interest: Radiotherapy, Proton Therapy, Particle Therapy, Gastrointestinal Cancers, Genitourinary Cancers, Anal Canal Cancer, Rectal Cancer, Gastric Cancer, Seminoma, Bladder Cancer, Prostate Cancer


    More Info.
    Julius Strauss
    Associate Investigator
    National Cancer Institute
    Thomas Aquinas College
    USA
    julius.strauss@nih.gov
    GJCT

    Research Interest: Cancer Immunotherapies  Therapeutic Cancer Vaccines, Genitourinary Malignancies

    More Info.
    Yatendra Kumar Satija
    Yatendra Kumar Satija Molecular Oncology Lab
    National Institute of Immunology
    USA
    yksatija@gmail.com
    GJCT

    Research Interest: Haematology Including Body Fluids, Clinical Biochemistry, Blood Bank, Clinical Microbiology, Cyto- Histopathology

    More Info.
    Vijai Kant Agnihotri
    Scientist
    Institute of Himalayan Bioresource Technology
    India
    kantvijai@yahoo.com
    GJCT

    Research Interest: Natural Product Chemistry, Toxicology, Spectroscopy, Essential Oils

    More Info.
    Hua Yang
    Department of Cell Biology
    Peking University,
    China
    yanghua@bjmu.edu.cn
    GJCT

    Research Interest: Oncology,including basic and clinical


    More Info.
    Xingding Zhang
    Assistant Professor
    Diagnosis and Nanomedicine Engineering Technology Center
    China
    ading5@hotmail.com
    GJCT

    Research Interest: Autophagy and Apoptosis


    More Info.
    Prakash Paudyal
    Department of Pharmacology
    The University of Lowa
    USA
    ppaudyal2003@yahoo.com
    GJCT

    Research Interest: Role of GPCR signaling in cancer progression and metastasis.


    More Info.
    View more
    mendeley

    Total Oncology is necessary for Japanese new era e-certificate

    DOI Logo 10.17352/2581-5407.000022

    Published On: October 13, 2018 | Pages: 001 - 003

    Author(s): Tsuyoshi Shirakawa*
    Abstract View Full Article View Get Citation

    CrossMark

    mendeley

    Video Endoscopic Inguinal Lymphadenectomy: Refi ning surgical technique after ten years experience e-certificate

    DOI Logo 10.17352/gjct.000021

    Published On: December 30, 2017 | Pages: 034 - 037

    Author(s): Marcos Tobias-Machado, Pericles Rios Auad*, Victor Corona, Igor Silva, Oseas de Castro Neves, Eliney Ferreira Faria, Pablo Matos, Alexandre Cesar Santos, Roberto Machado, Aurus Dourado and Hamilton de Campos Zampolli
    Abstract View Full Article View Get Citation

    CrossMark

    mendeley

    Role of tumor heterogeneity in drug resistance e-certificate

    DOI Logo 10.17352/gjct.000020

    Published On: July 20, 2017 | Pages: 032 - 033

    Author(s): Dhruv Kumar*
    Abstract View Full Article View Get Citation

    CrossMark

    mendeley

    MEK Inhibitors in Combination with Immune Checkpoint Inhibition: Should we be Chasing Colorectal Cancer or the KRAS Mutant Cancer e-certificate

    DOI Logo 10.17352/gjct.000019

    Published On: May 26, 2017 | Pages: 030 - 031

    Author(s): Julius Strauss*
    Abstract View Full Article View Get Citation

    CrossMark

    mendeley

    Angiosarcoma of the Scalp and Face: A Hard to Treat Tumor e-certificate

    DOI Logo 10.17352/gjct.000018

    Published On: April 15, 2017 | Pages: 026 - 029

    Author(s): Jmour Omar*, Kochbati Lotfi , Ghith Sahar and Benna Farouk
    Abstract View Full Article View Get Citation

    CrossMark

    mendeley

    The Promise of Disease Management in Greece e-certificate

    DOI Logo 10.17352/gjct.000017

    Published On: March 30, 2017 | Pages: 018 - 025

    Author(s): Konstantinos Stamatiou, Richard Lacroix, Eleni Almpani, Konstantinos Katsanos, Georgios Tzitzikos and Maria Saridi*
    Abstract View Full Article View Get Citation

    CrossMark

    mendeley

    Abrikossoff’s Tumour Mimicking a Neoplastic Tumour of the Breast: A Case Report e-certificate

    DOI Logo 10.17352/gjct.000016

    Published On: March 20, 2017 | Pages: 015 - 017

    Author(s): Alassiri A*, Al Ali A, Vaysse C, Escourrou G, Vinet B and Rimailho J
    Abstract View Full Article View Get Citation

    CrossMark

    mendeley

    The Role of Decavanadate in Anti- Tumour Activity e-certificate

    DOI Logo 10.17352/gjct.000015

    Published On: March 11, 2017 | Pages: 012 - 014

    Author(s): M Aureliano*
    Abstract View Full Article View Get Citation

    CrossMark

    mendeley

    Diagnosing HPV-Related Oropharyngeal Cancers: The Need to Speak a Common Language e-certificate

    DOI Logo 10.17352/gjct.000014

    Published On: March 07, 2017 | Pages: 008 - 011

    Author(s): Daniela Russo#, Francesco Merolla#, Gennaro Ilardi*, Silvia Varricchio, Danila Caroppo, Virginia Napolitano, Massimo Mascolo and Stefania Staibano
    Abstract View Full Article View Get Citation

    CrossMark

    mendeley

    Is it Time for the Introduction of Colostomy Free Survival in Rectal Cancer Patients e-certificate

    DOI Logo 10.17352/gjct.000013

    Published On: February 28, 2017 | Pages: 004 - 007

    Author(s): Mostafa El Haddad*
    Abstract View Full Article View Get Citation

    CrossMark

     

    Clients' voices

    Readmore

    Find more...

    Global Views

    Case Reports

    Peertechz Tweets

    Pinterest on GJCT